FI973484L - Menetelmä immuunivasteen stimuloimiseksi - Google Patents

Menetelmä immuunivasteen stimuloimiseksi Download PDF

Info

Publication number
FI973484L
FI973484L FI973484A FI973484A FI973484L FI 973484 L FI973484 L FI 973484L FI 973484 A FI973484 A FI 973484A FI 973484 A FI973484 A FI 973484A FI 973484 L FI973484 L FI 973484L
Authority
FI
Finland
Prior art keywords
immune response
stimulating immune
stimulating
response
immune
Prior art date
Application number
FI973484A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973484A7 (fi
FI973484A0 (fi
Inventor
Mark Alderson
Kim A Campbell
Mary K Kennedy
Charles R Maliszewski
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of FI973484A0 publication Critical patent/FI973484A0/fi
Publication of FI973484A7 publication Critical patent/FI973484A7/fi
Publication of FI973484L publication Critical patent/FI973484L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI973484A 1995-03-01 1996-02-29 Menetelmä immuunivasteen stimuloimiseksi FI973484L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39623095A 1995-03-01 1995-03-01
PCT/US1996/002839 WO1996026735A1 (en) 1995-03-01 1996-02-29 Method for stimulating an immune response

Publications (3)

Publication Number Publication Date
FI973484A0 FI973484A0 (fi) 1997-08-25
FI973484A7 FI973484A7 (fi) 1997-10-24
FI973484L true FI973484L (fi) 1997-10-24

Family

ID=23566398

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973484A FI973484L (fi) 1995-03-01 1996-02-29 Menetelmä immuunivasteen stimuloimiseksi

Country Status (15)

Country Link
EP (1) EP0812206B1 (de)
JP (1) JP3657271B2 (de)
KR (1) KR19980702490A (de)
AT (1) ATE220331T1 (de)
AU (1) AU699291B2 (de)
CA (1) CA2213798C (de)
DE (1) DE69622259T2 (de)
DK (1) DK0812206T3 (de)
ES (1) ES2179187T3 (de)
FI (1) FI973484L (de)
MX (1) MX9706588A (de)
NO (1) NO973875L (de)
NZ (1) NZ305083A (de)
PT (1) PT812206E (de)
WO (1) WO1996026735A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033406A4 (de) * 1997-10-27 2005-03-09 Sumitomo Electric Industries Induktor zur herstellung eines antigen-spezifischen antikörpers, expressionsvektor enthaltend ein hierfür entsprechendes gen, sowie verfahren zur induktion der herstellung eines antigen-spezifischen antikörpers
JP2001526241A (ja) * 1997-12-19 2001-12-18 イミュネックス・コーポレーション Ｈｉｖ感染に対する感受性を低下させるための方法
CN1762492A (zh) * 1998-05-23 2006-04-26 莱顿大学医学中心 Cd40结合分子和ctl肽在用于治疗肿瘤的药物组合物中的用途
US7371392B2 (en) 2000-02-02 2008-05-13 The United States Of America As Represented By The Department Of Health And Human Services Cd40 ligand adjuvant for respiratory syncytial virus
MY183797A (en) 2006-09-18 2021-03-16 Univ Arkansas Compositions and methods of enhancing immune responses
US9125854B2 (en) 2007-10-30 2015-09-08 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
BRPI0819229B1 (pt) 2007-11-01 2019-01-22 The Board Of Trustees Of The University Of Arkansas vacinas para reforçar reações imunes contra eimeria
NZ601609A (en) 2010-01-21 2014-08-29 Univ Arkansas Vaccine vectors and methods of enhancing immune responses
JP5746333B2 (ja) 2010-06-09 2015-07-08 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー カンピロバクター感染を減少させるワクチン及び方法
ES2709654T3 (es) 2011-04-29 2019-04-17 Apexigen Inc Anticuerpos anti-CD40 y métodos de uso
EP3925977A1 (de) 2012-10-30 2021-12-22 Apexigen, Inc. Anti-cd40-antikörper und verfahren zur verwendung
WO2014127185A1 (en) 2013-02-14 2014-08-21 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
MY173901A (en) 2013-03-15 2020-02-26 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to enteric pathogens
CN116196426A (zh) 2015-07-16 2023-06-02 百欧肯治疗有限公司 治疗癌症的组合物及方法
SG11201808821WA (en) 2016-04-18 2018-11-29 Celldex Therapeutics Inc Agonistic antibodies that bind human cd40 and uses thereof
AU2017260323B2 (en) 2016-05-03 2023-11-16 The Board Of Trustees Of The University Of Arkansas Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0667901B2 (de) * 1991-10-25 2008-10-15 Immunex Corporation Neue cytokine
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
JP3675819B2 (ja) * 1993-10-01 2005-07-27 イミュネックス・コーポレーション Ｃｄ４０に対する抗体

Also Published As

Publication number Publication date
FI973484A7 (fi) 1997-10-24
MX9706588A (es) 1997-11-29
KR19980702490A (ko) 1998-07-15
NO973875D0 (no) 1997-08-22
AU699291B2 (en) 1998-11-26
PT812206E (pt) 2002-11-29
CA2213798A1 (en) 1996-09-06
CA2213798C (en) 2001-02-06
WO1996026735A1 (en) 1996-09-06
JP3657271B2 (ja) 2005-06-08
NZ305083A (en) 1999-06-29
FI973484A0 (fi) 1997-08-25
DE69622259T2 (de) 2003-03-27
AU5301196A (en) 1996-09-18
ES2179187T3 (es) 2003-01-16
ATE220331T1 (de) 2002-07-15
JPH11506418A (ja) 1999-06-08
EP0812206A1 (de) 1997-12-17
NO973875L (no) 1997-10-31
DK0812206T3 (da) 2002-09-09
DE69622259D1 (de) 2002-08-14
EP0812206B1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
FI970059A7 (fi) Menetelmä immunifunktion säätelemiseksi
FI935898A7 (fi) Menetelmä immuunivasteen stimuloimiseksi
FI101829B1 (fi) Biospesifinen määritysmenetelmä
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
FI944619A7 (fi) Aldolisointi-dehydratointimenetelmä
DE69623712D1 (de) Schnittsystem
DE69633638D1 (de) Flussmittelfreiverfahren
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
NO975730D0 (no) Metode for ökning av beskyttende immunresponser
FI973484A7 (fi) Menetelmä immuunivasteen stimuloimiseksi
DE69629142D1 (de) Verpackungs-Verfahren
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI961879L (fi) Aromatisointimenetelmä
DE59603974D1 (de) Schraubensicherung
DE59609250D1 (de) Stimulationssystem
FI960979L (fi) Menetelmä humorralisen immuunivasteen suppressoimiseksi
DE59609297D1 (de) Wirbelschicht-Einrichtung
DK96392D0 (da) Modifikationsmetode
FI954832L (fi) Uuttomenetelmä
FI2165U1 (fi) Skyddande trosor med aoteranvaendbar sugdel
FR2736272B1 (fr) Stimulateur lombo-abdominal
LV10027A (lv) Broileru edinasanas metode
DE69532458D1 (de) Polierverfahren
UA25109A (uk) Спосіб створюваhhя холедоходуодеhоаhастомозу
UA25110A (uk) Спосіб біліосорбції